Half a year after selling its assets at bankruptcy auction, Pear Therapeutics’ most significant digital treatments will find a new life as part of PursueCare, which provides online addiction care and ...
Pear Therapeutics announced today that reSET-O, a digital therapeutic for opioid use disorder, has received an Expedited Access Pathway (EAP) designation from the FDA. The EAP designation doesn't mean ...
Pear’s reSET-O® is the first US FDA-authorized Prescription Digital Therapeutic for patients with Opioid Use Disorder BOSTON & GREENVILLE, S.C.--(BUSINESS WIRE)--Adults struggling with Opioid Use ...
The opioid epidemic has reached critical proportions in the United States, with more than 115 people dying from opioid overdose every day. In response to a crisis created by pharmaceuticals, some ...
BOSTON & SAN FRANCISCO--(BUSINESS WIRE)--Pear Therapeutics, Inc. announced today that the Indiana Family and Social Services Administration’s Division of Mental Health and Addiction (DMHA) is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results